Author:
Rosenberg Steven A.,Sherry Richard M.,Morton Kathleen E.,Yang James C.,Topalian Suzanne L.,Royal Richard E.,Kammula Udai S.,Restifo Nicholas P.,Hughes Marybeth S.,Schwarz Susan L.,Ngo Lien T.,Mavroukakis Sharon A.,White Donald E.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology,Immunology,Immunology and Allergy
Reference21 articles.
1. Progress in human tumour immunology and immunotherapy;Rosenberg;Nature,2001
2. The first 1000 dendritic cell vaccines;Ridgway;Cancer Invest,2003
3. Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0210 binding residues;Parkhurst;J Immunol,1996
4. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues;Valmori;J Immunol,1998
5. Cancer immunotherapy: moving beyond current vaccines;Rosenberg;Nat Med,2004
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献